Study: NCT01147900

Adverse event: Nasopharyngitis
Serious: no
Organ System: Infections and infestations
Notes: Unsolicited AE reported among subjects receiving the Booster dose of vaccine administered at Year 10.
Frequency: 6 affected / 55 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Notes: Unsolicited AE reported among subjects receiving the Booster dose of vaccine administered at Year 10.
Frequency: 5 affected / 55 at risk

Adverse event: Pain
Serious: no
Organ System: General disorders
Notes: Solicited local symptom assessed in and reported by subjects receiving the Booster dose of vaccine administered at Year 10.
Frequency: 50 affected / 55 at risk

Adverse event: Erythema
Serious: no
Organ System: General disorders
Notes: Solicited local symptom assessed in and reported by subjects receiving the Booster dose of vaccine administered at Year 10.
Frequency: 23 affected / 55 at risk

Adverse event: Swelling
Serious: no
Organ System: General disorders
Notes: Solicited local symptom assessed in and reported by subjects receiving the Booster dose of vaccine administered at Year 10.
Frequency: 21 affected / 55 at risk

Adverse event: Fatigue
Serious: no
Organ System: General disorders
Notes: Solicited general symptom reported by subjects who received Year 10 booster vaccination and with available results.
Frequency: 17 affected / 54 at risk

Adverse event: Gastrointestinal symptoms
Serious: no
Organ System: General disorders
Notes: Solicited general symptom reported by subjects who received Year 10 booster vaccination and with available results.
Frequency: 10 affected / 54 at risk

Adverse event: Headache
Serious: no
Organ System: General disorders
Notes: Solicited general symptom reported by subjects who received Year 10 booster vaccination and with available results.
Frequency: 13 affected / 54 at risk

Adverse event: Nasopharyngitis
Serious: no
Organ System: Infections and infestations
Notes: Unsolicited AE reported among subjects receiving the Booster dose of vaccine administered at Year 10.
Frequency: 1 affected / 60 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Notes: Unsolicited AE reported among subjects receiving the Booster dose of vaccine administered at Year 10.
Frequency: 1 affected / 60 at risk

Adverse event: Pain
Serious: no
Organ System: General disorders
Notes: Solicited local symptom assessed in and reported by subjects receiving the Booster dose of vaccine administered at Year 10.
Frequency: 55 affected / 59 at risk

Adverse event: Erythema
Serious: no
Organ System: General disorders
Notes: Solicited local symptom assessed in and reported by subjects receiving the Booster dose of vaccine administered at Year 10.
Frequency: 23 affected / 59 at risk

Adverse event: Swelling
Serious: no
Organ System: General disorders
Notes: Solicited local symptom assessed in and reported by subjects receiving the Booster dose of vaccine administered at Year 10.
Frequency: 20 affected / 59 at risk

Adverse event: Fatigue
Serious: no
Organ System: General disorders
Notes: Solicited general symptom reported by subjects who received Year 10 booster vaccination and with available results.
Frequency: 20 affected / 59 at risk

Adverse event: Gastrointestinal symptoms
Serious: no
Organ System: General disorders
Notes: Solicited general symptom reported by subjects who received Year 10 booster vaccination and with available results.
Frequency: 9 affected / 59 at risk

Adverse event: Headache
Serious: no
Organ System: General disorders
Notes: Solicited general symptom reported by subjects who received Year 10 booster vaccination and with available results.
Frequency: 19 affected / 59 at risk

Adverse event: Nasopharyngitis
Serious: no
Organ System: Infections and infestations
Notes: Unsolicited AE reported among subjects receiving the Booster dose of vaccine administered at Year 10.
Frequency: 4 affected / 62 at risk

Adverse event: Headache
Serious: no
Organ System: Nervous system disorders
Notes: Unsolicited AE reported among subjects receiving the Booster dose of vaccine administered at Year 10.
Frequency: 3 affected / 62 at risk

Adverse event: Pain
Serious: no
Organ System: General disorders
Notes: Solicited local symptom assessed in and reported by subjects receiving the Booster dose of vaccine administered at Year 10.
Frequency: 54 affected / 62 at risk

Adverse event: Erythema
Serious: no
Organ System: General disorders
Notes: Solicited local symptom assessed in and reported by subjects receiving the Booster dose of vaccine administered at Year 10.
Frequency: 21 affected / 62 at risk

Adverse event: Swelling
Serious: no
Organ System: General disorders
Notes: Solicited local symptom assessed in and reported by subjects receiving the Booster dose of vaccine administered at Year 10.
Frequency: 19 affected / 62 at risk

Adverse event: Fatigue
Serious: no
Organ System: General disorders
Notes: Solicited general symptom reported by subjects who received Year 10 booster vaccination and with available results.
Frequency: 22 affected / 62 at risk

Adverse event: Gastrointestinal symptoms
Serious: no
Organ System: General disorders
Notes: Solicited general symptom reported by subjects who received Year 10 booster vaccination and with available results.
Frequency: 13 affected / 62 at risk

Adverse event: Headache
Serious: no
Organ System: General disorders
Notes: Solicited general symptom reported by subjects who received Year 10 booster vaccination and with available results.
Frequency: 13 affected / 62 at risk